Globenewswire·2025-09-26 16:05Core Viewpoint - Class action lawsuits have been filed against several publicly-traded companies, alleging that these companies made materially false and misleading statements regarding their business operations and prospects, which led to investor losses [1]. Group 1: Cytokinetics, Incorporated (NASDAQ: CYTK) - The class period for Cytokinetics is from December 27, 2023, to May 6, 2025, with a lead plaintiff deadline of November 17, 2025 [2]. - Allegations include the failure to disclose the omission of a Risk Evaluation and Mitigation Strategy (REMS) from the initial New Drug Application (NDA), which resulted in a three-month delay in FDA approval processes [2]. - Defendants' positive statements about the company's business were deemed materially misleading due to these omissions [2]. Group 2: Quanex Building Products Corporation (NYSE: NX) - The class period for Quanex is from December 12, 2024, to September 5, 2025, with a lead plaintiff deadline of November 18, 2025 [4]. - The complaint alleges that the company underinvested in tooling and equipment maintenance, leading to degraded conditions that could incur significant costs and delay expected benefits from integration efforts [4]. - Positive statements made by the defendants regarding the company's operations were found to lack a reasonable basis due to these undisclosed issues [4]. Group 3: Jasper Therapeutics, Inc. (NASDAQ: JSPR) - The class period for Jasper is from November 30, 2023, to July 3, 2025, with a lead plaintiff deadline of November 18, 2025 [6]. - Allegations include the lack of necessary controls to ensure third-party manufacturers complied with current Good Manufacturing Practices (cGMP), which could negatively impact clinical trial results and the company's product prospects [6]. - Defendants' positive statements about the company's business and financial prospects were considered materially misleading due to these failures [6]. Group 4: KBR, Inc. (NYSE: KBR) - The class period for KBR is from May 6, 2025, to June 19, 2025, with a lead plaintiff deadline of November 18, 2025 [8]. - The complaint alleges that the company misled investors about the partnership with TRANSCOM, despite knowing of material concerns regarding HomeSafe's ability to fulfill contract obligations [8]. - Positive statements made by the defendants regarding the company's operations were found to lack a reasonable basis due to these undisclosed concerns [8].